Wave Life Sciences (WVE) Enterprise Value (2016 - 2025)
Wave Life Sciences (WVE) has disclosed Enterprise Value for 11 consecutive years, with -$602.1 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 99.32% year-over-year to -$602.1 million, compared with a TTM value of -$602.1 million through Dec 2025, down 99.32%, and an annual FY2025 reading of -$602.1 million, down 99.32% over the prior year.
- Enterprise Value was -$602.1 million for Q4 2025 at Wave Life Sciences, down from -$196.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$88.5 million in Q4 2022 and bottomed at -$602.1 million in Q4 2025.
- Average Enterprise Value over 5 years is -$202.8 million, with a median of -$173.1 million recorded in 2022.
- The sharpest move saw Enterprise Value skyrocketed 42.74% in 2021, then tumbled 126.39% in 2023.
- Year by year, Enterprise Value stood at -$150.6 million in 2021, then soared by 41.22% to -$88.5 million in 2022, then plummeted by 126.39% to -$200.4 million in 2023, then crashed by 50.77% to -$302.1 million in 2024, then plummeted by 99.32% to -$602.1 million in 2025.
- Business Quant data shows Enterprise Value for WVE at -$602.1 million in Q4 2025, -$196.2 million in Q3 2025, and -$208.5 million in Q2 2025.